Current and Future Perspectives on Clinical Management of Classic 21-Hydroxylase Deficiency

    January 2023 in “ Endocrine Journal ”
    Analia Yogi, Kenichi Kashimada
    Studysummary This review discusses the challenges in optimizing glucocorticoid treatment for classic 21-hydroxylase deficiency, emphasizing individualized care and the need for comprehensive management, but presents no new findings.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jstage.jst.go.jp →
    Discuss this study in the Community →

    Research cited in this study 4

    1. Congenital Adrenal Hyperplasia: Current Insights in Pathophysiology, Diagnostics, and Management Endocrine Reviews · 2021
    2. Influence of Genotype and Hyperandrogenism on Sexual Function in Women With Congenital Adrenal Hyperplasia The Journal of Sexual Medicine · 2019
    3. The Modified Ferriman-Gallwey Score and Hirsutism Among Filipino Women Endocrinology and metabolism · 2019
    4. Epidemiology, Diagnosis, and Management of Hirsutism: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome Society Human reproduction update · 2011